Loading…

Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions

Propofol is routinely combined with opioid analgesics to ensure adequate anesthesia during surgery. The aim of the study was to assess the effect of fentanyl on the hypnotic effect of propofol and the possible clinical implications of this interaction. The pharmacokinetic/pharmacodynamic (PK/PD) dat...

Full description

Saved in:
Bibliographic Details
Published in:Biopharmaceutics & drug disposition 2016-07, Vol.37 (5), p.252-263
Main Authors: Wiczling, Paweł, Bieda, Krzysztof, Przybyłowski, Krzysztof, Hartmann-Sobczyńska, Roma, Borsuk, Agnieszka, Matysiak, Jan, Kokot, Zenon J., Sobczyński, Paweł, Grześkowiak, Edmund, Bienert, Agnieszka
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3879-8b6c1031ac1448508fbafa0ba343529b8ccbeb974ea5085eddd40b0c79eab5383
cites cdi_FETCH-LOGICAL-c3879-8b6c1031ac1448508fbafa0ba343529b8ccbeb974ea5085eddd40b0c79eab5383
container_end_page 263
container_issue 5
container_start_page 252
container_title Biopharmaceutics & drug disposition
container_volume 37
creator Wiczling, Paweł
Bieda, Krzysztof
Przybyłowski, Krzysztof
Hartmann-Sobczyńska, Roma
Borsuk, Agnieszka
Matysiak, Jan
Kokot, Zenon J.
Sobczyński, Paweł
Grześkowiak, Edmund
Bienert, Agnieszka
description Propofol is routinely combined with opioid analgesics to ensure adequate anesthesia during surgery. The aim of the study was to assess the effect of fentanyl on the hypnotic effect of propofol and the possible clinical implications of this interaction. The pharmacokinetic/pharmacodynamic (PK/PD) data were obtained from 11 patients undergoing abdominal aortic surgery, classified as ASA III. Propofol was administered by a target‐controlled infusion system. Fentanyl 2–3 µg/kg was given whenever insufficient analgesia occurred. The bispectral index (BIS) was used to monitor the depth of anesthesia. A population PK/PD analysis with a non‐linear mixed‐effect model (NONMEM 7.2 software) was conducted. Two‐compartment models satisfactorily described the PK of propofol and fentanyl. The delay of the anesthetic effect in relation to PK was described by the effect compartment. The BIS was linked to propofol and fentanyl effect‐site concentrations through an additive Emax model. Context‐sensitive decrement times (CSDT) determined from the final model were used to assess the influence of fentanyl on the recovery after anesthesia. The population PK/PD model was successfully developed to describe simultaneously the time course and variability of propofol and fentanyl concentrations and BIS. Additive propofol–fentanyl interactions were observed and quantitated. The duration of the fentanyl infusion had minimal effect on CSDT when it was shorter than the duration of the propofol infusion. If the fentanyl infusion was longer than the propofol infusion, an almost two‐fold increase in CSDT occurred. Additional doses of fentanyl administered after the cessation of the propofol infusion result in lower BIS values, and can prolong the time of recovery from anesthesia. Copyright © 2016 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/bdd.2009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1806078671</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1806078671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3879-8b6c1031ac1448508fbafa0ba343529b8ccbeb974ea5085eddd40b0c79eab5383</originalsourceid><addsrcrecordid>eNp1kcuO1DAQRS0EYpoBiS9AltiwyVDO01lCDwyPFrAAwc4qP9J4JrGDnQjyO3wp7p4wCCQ2Lrnq6JRKl5CHDM4YQP5Uan2WA7S3yIZB22bA2ZfbZAOszLO84fkJuRfjJQDUjLG75CSv2xagqDbk54evGAZU_so6M1kVKTpNx7WpF4fDoek7OgY_-s73R6AzbkK39NQ6OuJk0zfS2WkT9t66PUWp_WAdJtqHpKVxDnsTFppRpHGa9XJU_r2G6jDvs8OTtJMJqCbrXbxP7nTYR_Ngrafk08sXH7evst37i9fbZ7tMFbxpMy5rxaBgqFhZ8gp4J7FDkFiURZW3kisljWyb0mAaVkZrXYIE1bQGZVXw4pQ8ufamS7_NJk5isFGZvkdn_BwF41BDw-uGJfTxP-iln0M690hVaT_w-o9QBR9jMJ0Ygx0wLIKBOOQmUm7ikFtCH63CWQ5G34C_g0pAdg18t71Z_isSz8_PV-HK2ziZHzc8hitRN0VTic_vLkRT73hZb9-KN8UvSYiz_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805448086</pqid></control><display><type>article</type><title>Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Wiczling, Paweł ; Bieda, Krzysztof ; Przybyłowski, Krzysztof ; Hartmann-Sobczyńska, Roma ; Borsuk, Agnieszka ; Matysiak, Jan ; Kokot, Zenon J. ; Sobczyński, Paweł ; Grześkowiak, Edmund ; Bienert, Agnieszka</creator><creatorcontrib>Wiczling, Paweł ; Bieda, Krzysztof ; Przybyłowski, Krzysztof ; Hartmann-Sobczyńska, Roma ; Borsuk, Agnieszka ; Matysiak, Jan ; Kokot, Zenon J. ; Sobczyński, Paweł ; Grześkowiak, Edmund ; Bienert, Agnieszka</creatorcontrib><description>Propofol is routinely combined with opioid analgesics to ensure adequate anesthesia during surgery. The aim of the study was to assess the effect of fentanyl on the hypnotic effect of propofol and the possible clinical implications of this interaction. The pharmacokinetic/pharmacodynamic (PK/PD) data were obtained from 11 patients undergoing abdominal aortic surgery, classified as ASA III. Propofol was administered by a target‐controlled infusion system. Fentanyl 2–3 µg/kg was given whenever insufficient analgesia occurred. The bispectral index (BIS) was used to monitor the depth of anesthesia. A population PK/PD analysis with a non‐linear mixed‐effect model (NONMEM 7.2 software) was conducted. Two‐compartment models satisfactorily described the PK of propofol and fentanyl. The delay of the anesthetic effect in relation to PK was described by the effect compartment. The BIS was linked to propofol and fentanyl effect‐site concentrations through an additive Emax model. Context‐sensitive decrement times (CSDT) determined from the final model were used to assess the influence of fentanyl on the recovery after anesthesia. The population PK/PD model was successfully developed to describe simultaneously the time course and variability of propofol and fentanyl concentrations and BIS. Additive propofol–fentanyl interactions were observed and quantitated. The duration of the fentanyl infusion had minimal effect on CSDT when it was shorter than the duration of the propofol infusion. If the fentanyl infusion was longer than the propofol infusion, an almost two‐fold increase in CSDT occurred. Additional doses of fentanyl administered after the cessation of the propofol infusion result in lower BIS values, and can prolong the time of recovery from anesthesia. Copyright © 2016 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0142-2782</identifier><identifier>EISSN: 1099-081X</identifier><identifier>DOI: 10.1002/bdd.2009</identifier><identifier>PMID: 26990035</identifier><identifier>CODEN: BDDID8</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>abdominal aortic surgery ; Aged ; Analgesics, Opioid - pharmacokinetics ; Analgesics, Opioid - pharmacology ; Anesthetics, Intravenous - pharmacokinetics ; Anesthetics, Intravenous - pharmacology ; Aorta, Abdominal - surgery ; Drug Interactions ; fentanyl ; Fentanyl - pharmacokinetics ; Fentanyl - pharmacology ; Humans ; Hypnotics and Sedatives - pharmacokinetics ; Hypnotics and Sedatives - pharmacology ; Middle Aged ; Models, Biological ; PK/PD ; propofol ; Propofol - pharmacokinetics ; Propofol - pharmacology</subject><ispartof>Biopharmaceutics &amp; drug disposition, 2016-07, Vol.37 (5), p.252-263</ispartof><rights>Copyright © 2016 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3879-8b6c1031ac1448508fbafa0ba343529b8ccbeb974ea5085eddd40b0c79eab5383</citedby><cites>FETCH-LOGICAL-c3879-8b6c1031ac1448508fbafa0ba343529b8ccbeb974ea5085eddd40b0c79eab5383</cites><orcidid>0000-0002-2878-3161</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26990035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wiczling, Paweł</creatorcontrib><creatorcontrib>Bieda, Krzysztof</creatorcontrib><creatorcontrib>Przybyłowski, Krzysztof</creatorcontrib><creatorcontrib>Hartmann-Sobczyńska, Roma</creatorcontrib><creatorcontrib>Borsuk, Agnieszka</creatorcontrib><creatorcontrib>Matysiak, Jan</creatorcontrib><creatorcontrib>Kokot, Zenon J.</creatorcontrib><creatorcontrib>Sobczyński, Paweł</creatorcontrib><creatorcontrib>Grześkowiak, Edmund</creatorcontrib><creatorcontrib>Bienert, Agnieszka</creatorcontrib><title>Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions</title><title>Biopharmaceutics &amp; drug disposition</title><addtitle>Biopharm. Drug Dispos</addtitle><description>Propofol is routinely combined with opioid analgesics to ensure adequate anesthesia during surgery. The aim of the study was to assess the effect of fentanyl on the hypnotic effect of propofol and the possible clinical implications of this interaction. The pharmacokinetic/pharmacodynamic (PK/PD) data were obtained from 11 patients undergoing abdominal aortic surgery, classified as ASA III. Propofol was administered by a target‐controlled infusion system. Fentanyl 2–3 µg/kg was given whenever insufficient analgesia occurred. The bispectral index (BIS) was used to monitor the depth of anesthesia. A population PK/PD analysis with a non‐linear mixed‐effect model (NONMEM 7.2 software) was conducted. Two‐compartment models satisfactorily described the PK of propofol and fentanyl. The delay of the anesthetic effect in relation to PK was described by the effect compartment. The BIS was linked to propofol and fentanyl effect‐site concentrations through an additive Emax model. Context‐sensitive decrement times (CSDT) determined from the final model were used to assess the influence of fentanyl on the recovery after anesthesia. The population PK/PD model was successfully developed to describe simultaneously the time course and variability of propofol and fentanyl concentrations and BIS. Additive propofol–fentanyl interactions were observed and quantitated. The duration of the fentanyl infusion had minimal effect on CSDT when it was shorter than the duration of the propofol infusion. If the fentanyl infusion was longer than the propofol infusion, an almost two‐fold increase in CSDT occurred. Additional doses of fentanyl administered after the cessation of the propofol infusion result in lower BIS values, and can prolong the time of recovery from anesthesia. Copyright © 2016 John Wiley &amp; Sons, Ltd.</description><subject>abdominal aortic surgery</subject><subject>Aged</subject><subject>Analgesics, Opioid - pharmacokinetics</subject><subject>Analgesics, Opioid - pharmacology</subject><subject>Anesthetics, Intravenous - pharmacokinetics</subject><subject>Anesthetics, Intravenous - pharmacology</subject><subject>Aorta, Abdominal - surgery</subject><subject>Drug Interactions</subject><subject>fentanyl</subject><subject>Fentanyl - pharmacokinetics</subject><subject>Fentanyl - pharmacology</subject><subject>Humans</subject><subject>Hypnotics and Sedatives - pharmacokinetics</subject><subject>Hypnotics and Sedatives - pharmacology</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>PK/PD</subject><subject>propofol</subject><subject>Propofol - pharmacokinetics</subject><subject>Propofol - pharmacology</subject><issn>0142-2782</issn><issn>1099-081X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kcuO1DAQRS0EYpoBiS9AltiwyVDO01lCDwyPFrAAwc4qP9J4JrGDnQjyO3wp7p4wCCQ2Lrnq6JRKl5CHDM4YQP5Uan2WA7S3yIZB22bA2ZfbZAOszLO84fkJuRfjJQDUjLG75CSv2xagqDbk54evGAZU_so6M1kVKTpNx7WpF4fDoek7OgY_-s73R6AzbkK39NQ6OuJk0zfS2WkT9t66PUWp_WAdJtqHpKVxDnsTFppRpHGa9XJU_r2G6jDvs8OTtJMJqCbrXbxP7nTYR_Ngrafk08sXH7evst37i9fbZ7tMFbxpMy5rxaBgqFhZ8gp4J7FDkFiURZW3kisljWyb0mAaVkZrXYIE1bQGZVXw4pQ8ufamS7_NJk5isFGZvkdn_BwF41BDw-uGJfTxP-iln0M690hVaT_w-o9QBR9jMJ0Ygx0wLIKBOOQmUm7ikFtCH63CWQ5G34C_g0pAdg18t71Z_isSz8_PV-HK2ziZHzc8hitRN0VTic_vLkRT73hZb9-KN8UvSYiz_w</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Wiczling, Paweł</creator><creator>Bieda, Krzysztof</creator><creator>Przybyłowski, Krzysztof</creator><creator>Hartmann-Sobczyńska, Roma</creator><creator>Borsuk, Agnieszka</creator><creator>Matysiak, Jan</creator><creator>Kokot, Zenon J.</creator><creator>Sobczyński, Paweł</creator><creator>Grześkowiak, Edmund</creator><creator>Bienert, Agnieszka</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2878-3161</orcidid></search><sort><creationdate>201607</creationdate><title>Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions</title><author>Wiczling, Paweł ; Bieda, Krzysztof ; Przybyłowski, Krzysztof ; Hartmann-Sobczyńska, Roma ; Borsuk, Agnieszka ; Matysiak, Jan ; Kokot, Zenon J. ; Sobczyński, Paweł ; Grześkowiak, Edmund ; Bienert, Agnieszka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3879-8b6c1031ac1448508fbafa0ba343529b8ccbeb974ea5085eddd40b0c79eab5383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>abdominal aortic surgery</topic><topic>Aged</topic><topic>Analgesics, Opioid - pharmacokinetics</topic><topic>Analgesics, Opioid - pharmacology</topic><topic>Anesthetics, Intravenous - pharmacokinetics</topic><topic>Anesthetics, Intravenous - pharmacology</topic><topic>Aorta, Abdominal - surgery</topic><topic>Drug Interactions</topic><topic>fentanyl</topic><topic>Fentanyl - pharmacokinetics</topic><topic>Fentanyl - pharmacology</topic><topic>Humans</topic><topic>Hypnotics and Sedatives - pharmacokinetics</topic><topic>Hypnotics and Sedatives - pharmacology</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>PK/PD</topic><topic>propofol</topic><topic>Propofol - pharmacokinetics</topic><topic>Propofol - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiczling, Paweł</creatorcontrib><creatorcontrib>Bieda, Krzysztof</creatorcontrib><creatorcontrib>Przybyłowski, Krzysztof</creatorcontrib><creatorcontrib>Hartmann-Sobczyńska, Roma</creatorcontrib><creatorcontrib>Borsuk, Agnieszka</creatorcontrib><creatorcontrib>Matysiak, Jan</creatorcontrib><creatorcontrib>Kokot, Zenon J.</creatorcontrib><creatorcontrib>Sobczyński, Paweł</creatorcontrib><creatorcontrib>Grześkowiak, Edmund</creatorcontrib><creatorcontrib>Bienert, Agnieszka</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biopharmaceutics &amp; drug disposition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiczling, Paweł</au><au>Bieda, Krzysztof</au><au>Przybyłowski, Krzysztof</au><au>Hartmann-Sobczyńska, Roma</au><au>Borsuk, Agnieszka</au><au>Matysiak, Jan</au><au>Kokot, Zenon J.</au><au>Sobczyński, Paweł</au><au>Grześkowiak, Edmund</au><au>Bienert, Agnieszka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions</atitle><jtitle>Biopharmaceutics &amp; drug disposition</jtitle><addtitle>Biopharm. Drug Dispos</addtitle><date>2016-07</date><risdate>2016</risdate><volume>37</volume><issue>5</issue><spage>252</spage><epage>263</epage><pages>252-263</pages><issn>0142-2782</issn><eissn>1099-081X</eissn><coden>BDDID8</coden><abstract>Propofol is routinely combined with opioid analgesics to ensure adequate anesthesia during surgery. The aim of the study was to assess the effect of fentanyl on the hypnotic effect of propofol and the possible clinical implications of this interaction. The pharmacokinetic/pharmacodynamic (PK/PD) data were obtained from 11 patients undergoing abdominal aortic surgery, classified as ASA III. Propofol was administered by a target‐controlled infusion system. Fentanyl 2–3 µg/kg was given whenever insufficient analgesia occurred. The bispectral index (BIS) was used to monitor the depth of anesthesia. A population PK/PD analysis with a non‐linear mixed‐effect model (NONMEM 7.2 software) was conducted. Two‐compartment models satisfactorily described the PK of propofol and fentanyl. The delay of the anesthetic effect in relation to PK was described by the effect compartment. The BIS was linked to propofol and fentanyl effect‐site concentrations through an additive Emax model. Context‐sensitive decrement times (CSDT) determined from the final model were used to assess the influence of fentanyl on the recovery after anesthesia. The population PK/PD model was successfully developed to describe simultaneously the time course and variability of propofol and fentanyl concentrations and BIS. Additive propofol–fentanyl interactions were observed and quantitated. The duration of the fentanyl infusion had minimal effect on CSDT when it was shorter than the duration of the propofol infusion. If the fentanyl infusion was longer than the propofol infusion, an almost two‐fold increase in CSDT occurred. Additional doses of fentanyl administered after the cessation of the propofol infusion result in lower BIS values, and can prolong the time of recovery from anesthesia. Copyright © 2016 John Wiley &amp; Sons, Ltd.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>26990035</pmid><doi>10.1002/bdd.2009</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-2878-3161</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0142-2782
ispartof Biopharmaceutics & drug disposition, 2016-07, Vol.37 (5), p.252-263
issn 0142-2782
1099-081X
language eng
recordid cdi_proquest_miscellaneous_1806078671
source Wiley-Blackwell Read & Publish Collection
subjects abdominal aortic surgery
Aged
Analgesics, Opioid - pharmacokinetics
Analgesics, Opioid - pharmacology
Anesthetics, Intravenous - pharmacokinetics
Anesthetics, Intravenous - pharmacology
Aorta, Abdominal - surgery
Drug Interactions
fentanyl
Fentanyl - pharmacokinetics
Fentanyl - pharmacology
Humans
Hypnotics and Sedatives - pharmacokinetics
Hypnotics and Sedatives - pharmacology
Middle Aged
Models, Biological
PK/PD
propofol
Propofol - pharmacokinetics
Propofol - pharmacology
title Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A47%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20and%20pharmacodynamics%20of%20propofol%20and%20fentanyl%20in%20patients%20undergoing%20abdominal%20aortic%20surgery%20-%20a%20study%20of%20pharmacodynamic%20drug-drug%20interactions&rft.jtitle=Biopharmaceutics%20&%20drug%20disposition&rft.au=Wiczling,%20Pawe%C5%82&rft.date=2016-07&rft.volume=37&rft.issue=5&rft.spage=252&rft.epage=263&rft.pages=252-263&rft.issn=0142-2782&rft.eissn=1099-081X&rft.coden=BDDID8&rft_id=info:doi/10.1002/bdd.2009&rft_dat=%3Cproquest_cross%3E1806078671%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3879-8b6c1031ac1448508fbafa0ba343529b8ccbeb974ea5085eddd40b0c79eab5383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1805448086&rft_id=info:pmid/26990035&rfr_iscdi=true